GSK's Shingrix New Prefilled Syringe Presentation Receives Positive CHMP Opinion
October 21, 2025
October 21, 2025
LONDON, England, Oct. 21 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:
* * *
GSK's Shingrix new prefilled syringe presentation receives positive CHMP opinion
* Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals
* Marketing authorisation in EU expected in December 2025
* Shingles affects approximately 1.7 million people in Eur . . .
* * *
GSK's Shingrix new prefilled syringe presentation receives positive CHMP opinion
* Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals
* Marketing authorisation in EU expected in December 2025
* Shingles affects approximately 1.7 million people in Eur . . .
